AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
US Market
Holding AXIM?
Track your performance easily

AXIM Biotechnologies (AXIM) Stock Price & Analysis

151 Followers

AXIM Stock Chart & Stats


AXIM Biotechnologies News

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

9.77%90.23%
― Other Institutional Investors
90.23% Public Companies and
Individual Investors

AXIM FAQ

What was AXIM Biotechnologies Inc’s price range in the past 12 months?
AXIM Biotechnologies Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
    What is AXIM Biotechnologies Inc’s market cap?
    Currently, no data Available
    When is AXIM Biotechnologies Inc’s upcoming earnings report date?
    AXIM Biotechnologies Inc’s upcoming earnings report date is Mar 19, 2018 which is 2428 days ago.
      How were AXIM Biotechnologies Inc’s earnings last quarter?
      AXIM Biotechnologies Inc released its earnings results on Aug 22, 2017. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
        Is AXIM Biotechnologies Inc overvalued?
        According to Wall Street analysts AXIM Biotechnologies Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does AXIM Biotechnologies Inc pay dividends?
          AXIM Biotechnologies Inc does not currently pay dividends.
          What is AXIM Biotechnologies Inc’s EPS estimate?
          AXIM Biotechnologies Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does AXIM Biotechnologies Inc have?
          AXIM Biotechnologies Inc has 301,958,830 shares outstanding.
            What happened to AXIM Biotechnologies Inc’s price movement after its last earnings report?
            AXIM Biotechnologies Inc reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of AXIM Biotechnologies Inc?
              Currently, no hedge funds are holding shares in AXIM
              ---

              AXIM Biotechnologies Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              -12.21%
              Trailing 12-Months

              Company Description

              AXIM Biotechnologies Inc

              AXIM Biotechnologies, Inc. is engaged in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. It also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in New York, NY.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              China Pharma Holdings
              CytoDyn
              Inmune Bio
              Relmada Therapeutics
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis